aTYR PHARMA INC Interest Income (Expense), Nonoperating, Net
aTYR PHARMA INC (ATYR) reported Interest Income (Expense), Nonoperating, Net of $65.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2017-03-16
- aTYR PHARMA INC interest income (expense), nonoperating, net for fiscal 2016 was $65.00K.
- aTYR PHARMA INC interest income (expense), nonoperating, net for fiscal 2015 was -$386.00K.
- aTYR PHARMA INC interest income (expense), nonoperating, net for fiscal 2014 was -$832.00K.
- aTYR PHARMA INC interest income (expense), nonoperating, net for fiscal 2013 was -$444.00K.
| Period end | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|
| 2016-12-31 | $65.00K 10-K · filed 2017-03-16 |
| 2015-12-31 | -$386.00K 10-K · filed 2017-03-16 |
| 2014-12-31 | -$832.00K 10-K · filed 2017-03-16 |
| 2013-12-31 | -$444.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |